2x3j
From Proteopedia
(Difference between revisions)
Line 2: | Line 2: | ||
<StructureSection load='2x3j' size='340' side='right' caption='[[2x3j]], [[Resolution|resolution]] 2.00Å' scene=''> | <StructureSection load='2x3j' size='340' side='right' caption='[[2x3j]], [[Resolution|resolution]] 2.00Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[2x3j]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Erwinia_chrysanthemi Erwinia chrysanthemi]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2X3J OCA]. <br> | + | <table><tr><td colspan='2'>[[2x3j]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Erwinia_chrysanthemi Erwinia chrysanthemi]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2X3J OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2X3J FirstGlance]. <br> |
- | </td></tr><tr><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ATP:ADENOSINE-5-TRIPHOSPHATE'>ATP</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=X3J:(2S)-2-{2-[(2-AMINOETHYL)AMINO]-2-OXOETHYL}-2-HYDROXYBUTANEDIOIC+ACID'>X3J</scene>< | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ATP:ADENOSINE-5-TRIPHOSPHATE'>ATP</scene>, <scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=X3J:(2S)-2-{2-[(2-AMINOETHYL)AMINO]-2-OXOETHYL}-2-HYDROXYBUTANEDIOIC+ACID'>X3J</scene></td></tr> |
- | <tr><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[2w02|2w02]], [[2w04|2w04]], [[2x3k|2x3k]], [[2w03|2w03]]</td></tr> | + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[2w02|2w02]], [[2w04|2w04]], [[2x3k|2x3k]], [[2w03|2w03]]</td></tr> |
- | <tr | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2x3j FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2x3j OCA], [http://www.rcsb.org/pdb/explore.do?structureId=2x3j RCSB], [http://www.ebi.ac.uk/pdbsum/2x3j PDBsum]</span></td></tr> |
- | + | </table> | |
- | <table> | + | |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 14: | Line 13: | ||
Structural Basis for Acyl Acceptor Specificity in the Achromobactin Biosynthetic Enzyme AcsD.,Schmelz S, Botting CH, Song L, Kadi NF, Challis GL, Naismith JH J Mol Biol. 2011 Sep 23;412(3):495-504. Epub 2011 Aug 1. PMID:21835184<ref>PMID:21835184</ref> | Structural Basis for Acyl Acceptor Specificity in the Achromobactin Biosynthetic Enzyme AcsD.,Schmelz S, Botting CH, Song L, Kadi NF, Challis GL, Naismith JH J Mol Biol. 2011 Sep 23;412(3):495-504. Epub 2011 Aug 1. PMID:21835184<ref>PMID:21835184</ref> | ||
- | From | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> |
</div> | </div> | ||
== References == | == References == | ||
Line 21: | Line 20: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Erwinia chrysanthemi]] | [[Category: Erwinia chrysanthemi]] | ||
- | [[Category: Challis, G L | + | [[Category: Challis, G L]] |
- | [[Category: Naismith, J H | + | [[Category: Naismith, J H]] |
- | [[Category: Schmelz, S | + | [[Category: Schmelz, S]] |
[[Category: Adenylation]] | [[Category: Adenylation]] | ||
[[Category: Alcaligin biosynthesis]] | [[Category: Alcaligin biosynthesis]] |
Revision as of 21:23, 3 January 2015
CO-COMPLEX STRUCTURE OF ACHROMOBACTIN SYNTHETASE PROTEIN D (ACSD) WITH ATP AND N-CITRYL-ETHYLENEDIAMINE FROM PECTOBACTERIUM CHRYSANTHEMI
|